These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 25583712
21. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing. Shenai S, Rodrigues C, Sadani M, Sukhadia N, Mehta A. Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590 [Abstract] [Full Text] [Related]
23. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. Tam KK, Leung KS, Siu GK, Chang KC, Wong SS, Ho PL, Leung EK, Yam WC. J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582 [Abstract] [Full Text] [Related]
26. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects. Wu X, Lu W, Shao Y, Song H, Li G, Li Y, Zhu L, Chen C. Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296 [Abstract] [Full Text] [Related]
27. Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents. Pandey S, Lavu E, Congdon J, Moke R, Bainomugisa A, Coulter C. Tuberculosis (Edinb); 2018 Jul; 111():109-113. PubMed ID: 30029894 [Abstract] [Full Text] [Related]
28. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A. BMC Microbiol; 2010 Aug 20; 10():223. PubMed ID: 20727143 [Abstract] [Full Text] [Related]
29. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide. Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G, “Union short MDR-TB regimen study group”. PLoS One; 2017 Aug 20; 12(10):e0187211. PubMed ID: 29088294 [Abstract] [Full Text] [Related]
30. [Prevalence and transmission of pyrazinamide-resistant Mycobacterium tuberculosis in Hunan Province,China]. Liu BB, Hu PL, Chen ZH, Yi SL, Zhang XP, Tan YH. Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul 12; 45(7):677-685. PubMed ID: 35768376 [Abstract] [Full Text] [Related]
31. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis. Zheng X, Ning Z, Drobniewski F, Yang J, Li Q, Zhang Z, Hu Y. Int J Antimicrob Agents; 2017 Feb 12; 49(2):183-188. PubMed ID: 28012685 [Abstract] [Full Text] [Related]
32. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda. Naluyange R, Mboowa G, Komakech K, Semugenze D, Kateete DP, Ssengooba W. PLoS One; 2020 Feb 12; 15(5):e0232543. PubMed ID: 32413052 [Abstract] [Full Text] [Related]
35. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT. BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001 [Abstract] [Full Text] [Related]
39. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. Park J, Shin SY, Kim K, Park K, Shin S, Ihm C. Ann Lab Med; 2018 Jul 06; 38(4):316-323. PubMed ID: 29611381 [Abstract] [Full Text] [Related]
40. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa. Bishop KS, Blumberg L, Trollip AP, Smith AN, Roux L, York DF, Kiepiela P. Int J Tuberc Lung Dis; 2001 Oct 06; 5(10):952-7. PubMed ID: 11605890 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]